Valiant Organics · NSE: VALIANTORG · BSE: 540145

Q4 FY24 results · Jan–Mar 2024

Valiant Organics reported revenue from operations of ₹176.76 crore (down 34.9% from Q4 FY23) and net loss of ₹20.19 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY24	Q4 FY23	YoY	Q3 FY24	QoQ
Revenue from operations	176.76	271.40	−34.9%	141.36	+25.0%
Other income	2.06	2.79	−26.2%	0.40	+420.0%
Total income	178.82	274.19	−34.8%	141.76	+26.1%
Profit before share of associates & JVs and tax	(24.77)	44.10	Turned loss	(8.61)	Loss widened
Share of profit/(loss) of associates & JVs	(0.36)	0.00		(1.20)
Net profit for the period	(20.19)	34.00	Turned loss	(7.89)	Loss widened
Attributable to shareholders of the company	(20.18)	29.76	Turned loss	(7.89)	Loss widened
EPS, basic (₹)	(3.90)	10.96	Turned loss	(2.90)	Loss widened
Net margin (%)	-11.4	12.5		-5.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY24	Q4 FY23	YoY	Q3 FY24	QoQ
Revenue from operations	176.76	227.17	−22.2%	141.36	+25.0%
Other income	2.06	0.62	+234.3%	0.40	+420.0%
Total income	178.82	227.78	−21.5%	141.76	+26.1%
Profit before tax	(15.59)	34.28	Turned loss	(8.61)	Loss widened
Net profit for the period	(10.64)	26.19	Turned loss	(6.69)	Loss widened
EPS, basic (₹)	(3.90)	9.64	Turned loss	(2.46)	Loss widened
Net margin (%)	-6.0	11.5		-4.7

Consolidated

Filed with BSE: 14 Jun 2024, 12:37 IST
Board meeting: 24 May 2024
Period: 01 Jan 2024 to 31 Mar 2024
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 14 Jun 2024, 12:37 IST
Board meeting: 24 May 2024
Period: 01 Jan 2024 to 31 Mar 2024
Review status: Audited
Source: XBRL filing on BSE